Cetera Trust Company, N.A Astrazeneca PLC Transaction History
Cetera Trust Company, N.A
- $164 Billion
- Q3 2024
A detailed history of Cetera Trust Company, N.A transactions in Astrazeneca PLC stock. As of the latest transaction made, Cetera Trust Company, N.A holds 4,175 shares of AZN stock, worth $277,220. This represents 0.2% of its overall portfolio holdings.
Number of Shares
4,175
Previous 4,175
-0.0%
Holding current value
$277,220
Previous $326 Million
0.1%
% of portfolio
0.2%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.18 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.79 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.47 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.44 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.28 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $206B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...